IMC Chicago
ROIV icon

IMC Chicago’s Roivant Sciences ROIV Stock Holding History

IMC Chicago’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Buy
+10,000
New +$257K ﹤0.01% 4686

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IMC Chicago's ROIV Position: Q1 2026 in Review

IMC Chicago opened a new position in Roivant Sciences (ROIV) in Q1 2026: 32,219 shares worth $892K. The stake represents ﹤0.01% of the portfolio and ranks #3391 among its holdings.

439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • IMC Chicago held 32,219 shares of Roivant Sciences worth $892K as of Q1 2026.
  • Roivant Sciences was a new IMC Chicago position in Q1 2026.
  • Roivant Sciences made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3391 holding.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.